Access the full text.
Sign up today, get DeepDyve free for 14 days.
R Peto, J Peto (1972)
Asymptomatically efficient rank invariant test proceduresJ Roy Stat Soc A, 135
G Singer, RJ Kurman, HW Chang, SK Cho, M Shih Ie (2002)
Diverse tumorigenic pathways in ovarian serous carcinomaAm J Pathol, 160
SG Silverberg (2000)
Histopathologic grading of ovarian carcinoma: a review and proposalInt J Gynecol Pathol, 19
WG McCluggage (2011)
Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesisPathology (Phila), 43
DV Cicchetti, AR Feinstein (1990)
High agreement but low kappa: II. Resolving the paradoxesJ Clin Epidemiol, 43
CJ Cohen (1960)
A coefficient of agreement for nominal scalesEduc Psychol Measur, 20
RA Soslow (2008)
Histologic subtypes of ovarian carcinoma: an overviewInt J Gynecol Pathol, 27
Y Shimizu, S Kamoi, S Amada, K Hasumi, F Akiyama, SG Silverberg (1998)
Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features–problems involved in the architectural grading systemGynecol Oncol, 70
A Malpica, MT Deavers, C Tornos, RJ Kurman, R Soslow, JD Seidman (2007)
Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinomaAm J Surg Pathol, 31
CB Gilks, DN Ionescu, SE Kalloger, M Kobel, J Irving, B Clarke (2008)
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinomaHum Pathol, 39
CN Landen, MJ Birrer, AK Sood (2008)
Early events in the pathogenesis of epithelial ovarian cancerJ Clin Oncol, 26
A Malpica, MT Deavers, K Lu, DC Bodurka, EN Atkinson, DM Gershenson (2004)
Grading ovarian serous carcinoma using a two-tier systemAm J Surg Pathol, 28
AR Feinstein, DV Cicchetti (1990)
High agreement but low kappa: I. The problems of two paradoxesJ Clin Epidemiol, 43
PM Grimley, RK Matsuno, PS Rosenberg, DE Henson, AM Schwartz, WF Anderson (2009)
Qualitative age interactions between low and high grade serous ovarian carcinomasCancer Epidemiol Biomarkers Prev, 18
JD Seidman, A Yemelyanova, JA Cosin, A Smith, RJ Kurman (2012)
Survival rates for international federation of gynecology and obstetrics stage III ovarian carcinoma by cell type: a study of 262 unselected patients with uniform pathologic reviewInt J Gynecol Cancer, 22
KT Kuo, B Guan, Y Feng, TL Mao, X Chen, N Jinawath (2009)
Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomasCancer Res, 69
Y Shimizu, S Kamoi, S Amada, F Akiyama, SG Silverberg (1998)
Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-upCancer, 82
RJ Kurman, IM Shih (2008)
Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implicationsInt J Gynecol Pathol, 27
M ShihIe, RJ Kurman (2004)
Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysisAm J Pathol, 164
C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds (2006)
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosisJ Natl Cancer Inst, 98
K Levanon, C Crum, R Drapkin (2008)
New insights into the pathogenesis of serous ovarian cancer and its clinical impactJ Clin Oncol, 26
EL Kaplan, P Meier (1958)
Nonparametric estimation from incomplete observationsJ Am Stat Assoc, 53
G Singer, M Shih Ie, A Truskinovsky, H Umudum, RJ Kurman (2003)
Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor)Int J Gynecol Pathol, 22
JM Last (1995)
A dictionary of epidemiology
A Malpica (2008)
Grading of ovarian cancer: a histotype-specific approachInt J Gynecol Pathol, 27
T Sugiyama, T Kamura, J Kigawa, N Terakawa, Y Kikuchi, T Kita (2000)
Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapyCancer, 88
M Kobel, SE Kalloger, N Boyd, S McKinney, E Mehl, C Palmer (2008)
Ovarian carcinoma subtypes are different diseases: implications for biomarker studiesPLoS Med, 5
C Sotiriou, L Pusztai (2009)
Gene-expression signatures in breast cancerN Engl J Med, 360
(2011)
AJCC cancer staging manual
MT Goodman, BY Hernandez, S Hewitt, CF Lynch, TR Cote, HF Frierson (2005)
Tissues from population-based cancer registries: a novel approach to increasing research potentialHum Pathol, 36
MM Leitao, J Boyd, A Hummer, N Olvera, CD Arroyo, E Venkatraman (2004)
Clinicopathologic analysis of early-stage sporadic ovarian carcinomaAm J Surg Pathol, 28
Grade agreement was fair between SEER and study pathologists irrespective of grading system. Recorded grade in SEER should be used with caution and is probably not a reliable metric for ovarian cancer epidemiology.
Cancer Causes & Control – Springer Journals
Published: Feb 3, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.